Weight loss start­up Cal­i­brate rais­es $29M as part of pri­vate eq­ui­ty re­struc­tur­ing

(This sto­ry is from our new Health Tech newslet­ter. If you’d like to sign up, just click here.)

Cal­i­brate, the weight loss start­up that rose in pop­u­lar­i­ty with the rise of GLP-1 med­ica­tions on­ly to strug­gle to get pa­tients ac­cess to those med­ica­tions — lead­ing to pa­tient com­plaints and re­funds — has raised $29 mil­lion as part of its re­struc­tur­ing un­der a pri­vate eq­ui­ty in­vestor.

The new fund­ing, which was dis­closed in a Wednes­day fil­ing with the Se­cu­ri­ties and Ex­change Com­mis­sion, comes as Cal­i­brate goes through ma­jor changes to its busi­ness. In­sid­er in Oc­to­ber re­port­ed that the pri­vate eq­ui­ty firm Madryn As­set Man­age­ment is buy­ing Cal­i­brate. Cal­i­brate pre­vi­ous­ly told Mod­ern Health­care it was re­ceiv­ing cap­i­tal from Madryn and ex­ist­ing in­vestors.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER